A new analytical method could improve how cancer treatments are designed - by allowing scientists to track, for the first time, exactly where inside a living cell a drug accumulates. Researchers from ...
A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the ...
We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.
The honorees are scheduled to deliver lectures during this year’s meeting in San Diego, CA, which runs from April 17-22.
A study found that in about 10 percent of patients, WGS picked up on clinically actionable information other panels missed.
Colorectal cancer may carry a unique microbial “fingerprint,” setting it apart from other cancers and opening a new frontier in diagnosis and treatment. By analyzing DNA from over 9,000 patients, ...
New research indicates that psychosocial factors—which influence how a person perceives, interprets, and reacts to their surroundings—do not affect an individual's risk of developing cancer. The ...
71% of high glyphosate counties have late-stage non-Hodgkin lymphoma rates above the national average High glyphosate use is linked to elevated rates of non-Hodgkin lymphoma cancer, particularly in ...
Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials Total ...
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...
Researchers have detected microplastics in nearly all prostate cancer tumors examined in a new study. Tumor tissue contained about 2.5 times more plastic than nearby healthy prostate tissue.
Pooled trials show Pluvicto improves progression-free survival in advanced prostate cancer, without increasing serious adverse events. An examination of data from more than 2500 patients with advanced ...